KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Operating Expenses (2016 - 2025)

Globus Medical (GMED) has disclosed Operating Expenses for 15 consecutive years, with $365.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses rose 5000.04% year-over-year to $365.5 million, compared with a TTM value of $402.9 million through Dec 2025, up 507.53%, and an annual FY2025 reading of $1.4 billion, up 1962.83% over the prior year.
  • Operating Expenses was $365.5 million for Q4 2025 at Globus Medical, up from $6.3 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $365.5 million in Q4 2025 and bottomed at -$519.4 million in Q4 2023.
  • Average Operating Expenses over 5 years is $52.7 million, with a median of $117.8 million recorded in 2021.
  • The sharpest move saw Operating Expenses crashed 318.07% in 2022, then surged 5000.04% in 2025.
  • Year by year, Operating Expenses stood at $170.0 million in 2021, then crashed by 318.07% to -$370.8 million in 2022, then crashed by 40.07% to -$519.4 million in 2023, then soared by 101.38% to $7.2 million in 2024, then soared by 5000.04% to $365.5 million in 2025.
  • Business Quant data shows Operating Expenses for GMED at $365.5 million in Q4 2025, $6.3 million in Q3 2025, and $22.4 million in Q2 2025.